Tennis star Cliff Richey — the number one ranked professional tennis player in the United States in 1970 who won 45 tournament titles over a 26-year career — sees tennis having a “resurgence” in the next five years, rebounding from loss of television profile relative to the PGA golf tour. He attributed decline to lack of investment in promotion by the USTA. The sport has improved because of technological advances in equipment, better training and stronger athletes — but “serving is still not as good as it could be” and “not a lot of strategy” is being played…

Depression is commonly reported in people with Alzheimer’s disease and its precursor, mild cognitive impairment, with several studies suggesting having a history of major depression may nearly double your risk of developing dementia later in life. However, it has been unclear if depression is a symptom of the disease or a potential cause of the disease…

Brief therapy at the GP’s surgery can effectively treat anxiety and depression. Researchers writing in the open access journal BMC Medicine found that cognitive behaviour therapy (CBT) was effective for treating anxiety disorders, while CBT, problem solving therapy (PST) and counseling were all equally effective in treating depression and mixed anxiety and depression. John Cape worked with a team of researchers from University College London to pool the results of 34 studies involving 3962 patients…

Depression is one of the most common forms of psychiatric disorder. It can occur at any time of life and it may affect children and adolescents as well as the elderly. However, depression can usually be suitably managed with the help of cognitive behavioral therapy. Researchers based at Johannes Gutenberg University Mainz have been able to demonstrate both the efficacy and the extent of the beneficial effect of routine psychotherapeutic treatment for depression…

High school seniors with excessive daytime sleepiness have an elevated risk for depression, suggests a research abstract presented on Wednesday, June 9, 2010, in San Antonio, Texas, at SLEEP 2010, the 24th annual meeting of the Associated Professional Sleep Societies LLC. Results indicate that high school seniors were three times more likely to have strong depression symptoms (odds ratio = 3.04) if they had excessive daytime sleepiness…

H. Lundbeck A/S (Lundbeck) announced that the first patients have been recruited and dosed in the new phase III programme using Lu AA21004 in major depression (MDD). The first patients have been recruited in Finland. As previously communicated filing of Lu AA21004 is anticipated in 2012. The extended phase III programme for Lu AA21004 is based on clinical data obtained until now…

Clinical Data, Inc. (NASDAQ: CLDA), announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s New Drug Application (NDA) for vilazodone for the treatment of major depressive disorder (MDD). Vilazodone is a dual-acting potent and selective serotonin reuptake inhibitor and a 5-HT1A receptor partial agonist.

Clinical Data, Inc. (NASDAQ: CLDA), announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company’s New Drug Application (NDA) for vilazodone for the treatment of major depressive disorder (MDD). Vilazodone is a dual-acting potent and selective serotonin reuptake inhibitor and a 5-HT1A receptor partial agonist. The NDA will be subject to a standard review…

New research published online in the Journal of the American Academy of Dermatology (JAAD) shows that treatment with STELARA(TM)(Black Triangle Drug) (ustekinumab) significantly improves symptoms of depression, anxiety and health-related quality of life in patients with moderate to severe psoriasis compared to placebo. These results are from an analysis of prespecified quality of life measures from one of the large, pivotal phase III trials for STELARA, PHOENIX 2. Psoriasis affects approximately 1.5 million people in the UK,[1,2] with 20-30% of those considered to have severe disease…

When people are under chronic stress, they tend to smoke, drink, use drugs and overeat to help cope with stress. These behaviors trigger a biological cascade that helps prevent depression, but they also contribute to a host of physical problems that eventually contribute to early death. That is the claim of University of Michigan social scientist James S. Jackson and colleagues in an article published in the May 2010 issue of the American Journal of Public Health…